XML 70 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Note 10 - Equity Compensation (Details Textual)
$ / shares in Units, $ in Millions
3 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
Share-based Payment Arrangement, Expense | $ $ 0.5 $ 0.4
The 2019 Omnibus Award Plan [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | shares 2,922,194  
Share-based Compensation Arrangement by Share-based Payment Award, Fungible Share Ratio 2.5  
The 2019 Omnibus Award Plan [Member] | Non-qualified Serviced-based and Inducement Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares 318,406  
The 2019 Omnibus Award Plan [Member] | Non-qualified Serviced-based and Inducement Stock Options [Member] | Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 6.80  
The 2019 Omnibus Award Plan [Member] | Non-qualified Serviced-based and Inducement Stock Options [Member] | Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 7.06  
The 2019 Omnibus Award Plan [Member] | Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares 134,017  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 6.80  
The 2019 Omnibus Award Plan [Member] | Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares 131,126  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 6.80